Indeed, our finding is supported by a previous study in patients with Rothmund–Thomson syndrome type 1, which showed that splicing mutations in the ANAPC1 gene resulted in decreased protein expression and skeletal abnormalities such as osteoporosis and bone fractures [24]. This evidence concerns the gene ANAPC1 and osteoporosis.